These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20010558)

  • 1. Federal stimulus adds momentum to sequencing stampede.
    Fox JL
    Nat Biotechnol; 2009 Dec; 27(12):1061-2. PubMed ID: 20010558
    [No Abstract]   [Full Text] [Related]  

  • 2. Oh no! Not another acronym?
    Wallner PE
    J Am Coll Radiol; 2004 Sep; 1(9):629. PubMed ID: 17411670
    [No Abstract]   [Full Text] [Related]  

  • 3. Basic instincts.
    Nat Nanotechnol; 2008 Feb; 3(2):59. PubMed ID: 18654454
    [No Abstract]   [Full Text] [Related]  

  • 4. Space materials research: hanging by a thread.
    Nat Mater; 2004 Dec; 3(12):837. PubMed ID: 15573105
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing number of companies found ineligible for SBIR funding.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 7. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechs get $1 billion windfall in R&D tax credits.
    Thiel K
    Nat Biotechnol; 2009 Dec; 27(12):1066. PubMed ID: 20010563
    [No Abstract]   [Full Text] [Related]  

  • 9. Little science, big bucks.
    DeFrancesco L
    Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
    [No Abstract]   [Full Text] [Related]  

  • 10. Germany biotech gets second chance.
    Sheridan C
    Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
    [No Abstract]   [Full Text] [Related]  

  • 11. Brussels backs nanotech.
    Nat Nanotechnol; 2007 Feb; 2(2):65. PubMed ID: 18654212
    [No Abstract]   [Full Text] [Related]  

  • 12. Cautious industry welcome for US flu vaccine plan.
    Kling J
    Nat Biotechnol; 2005 Dec; 23(12):1457-8. PubMed ID: 16333275
    [No Abstract]   [Full Text] [Related]  

  • 13. Windfall warning.
    Nature; 2009 Oct; 461(7266):847-8. PubMed ID: 19829323
    [No Abstract]   [Full Text] [Related]  

  • 14. Federal budget. Dems join Bush to boost HIV/AIDS program funds.
    AIDS Policy Law; 2001 Jun; 16(12):1, 4. PubMed ID: 11682827
    [No Abstract]   [Full Text] [Related]  

  • 15. Flat NIH funding threatens scientific progress.
    J Nucl Med; 2007 May; 48(5):15N, 22N. PubMed ID: 17475944
    [No Abstract]   [Full Text] [Related]  

  • 16. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs.
    Rinaldi A
    EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US budget emphasizes bioterrorism countermeasures.
    Fox JL
    Nat Biotechnol; 2004 Mar; 22(3):256-7. PubMed ID: 14990938
    [No Abstract]   [Full Text] [Related]  

  • 18. Italian science: greater expectations?
    Gambardella P
    Nat Mater; 2006 Oct; 5(10):757. PubMed ID: 17013400
    [No Abstract]   [Full Text] [Related]  

  • 19. Reform science? First, reset the economy.
    Rosei F
    Nat Mater; 2006 Oct; 5(10):757-8. PubMed ID: 17013399
    [No Abstract]   [Full Text] [Related]  

  • 20. ARRA boosts cancer programs but impact on personalized medicine unclear.
    Ratner M
    Nat Biotechnol; 2009 Dec; 27(12):1062. PubMed ID: 20010559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.